Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Altimmune Inc (ALT)

Altimmune Inc (ALT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 479,235
  • Shares Outstanding, K 37,150
  • Annual Sales, $ 8,190 K
  • Annual Income, $ -49,040 K
  • 60-Month Beta 1.36
  • Price/Sales 59.55
  • Price/Cash Flow N/A
  • Price/Book 1.89
Trade ALT with:

Options Overview

Details
  • Implied Volatility 149.28%
  • Historical Volatility 67.46%
  • IV Percentile 42%
  • IV Rank 33.41%
  • IV High 242.43% on 07/09/20
  • IV Low 102.54% on 01/14/21
  • Put/Call Vol Ratio 0.73
  • Today's Volume 964
  • Volume Avg (30-Day) 1,510
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 29,105
  • Open Int (30-Day) 18,225

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.39
  • Number of Estimates 3
  • High Estimate 0.26
  • Low Estimate -1.03
  • Prior Year -0.26
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.14 +4.37%
on 04/12/21
18.52 -31.59%
on 03/18/21
-4.09 (-24.40%)
since 03/12/21
3-Month
11.65 +8.76%
on 03/05/21
24.61 -48.52%
on 02/18/21
-1.02 (-7.45%)
since 01/13/21
52-Week
2.88 +339.93%
on 05/01/20
35.10 -63.90%
on 07/20/20
+9.41 (+288.65%)
since 04/13/20

Most Recent Stories

More News
Alternus Energy Group (ALT) Completes 9 Million (91 Million NOK) Funding, Led by Nordic ESG and Impact Investor, AV Group Sarl

via NewMediaWire - Fast-growing pan-European independent power producer, Alternus Energy Group Plc (NOTC: ALT) (the "Company", "Alternus" or "AEG"), is pleased to announce the recent issuance of EUR9 million...

ALTN : 0.0900 (+12.50%)
ALT : 12.67 (+0.80%)
Altimmune Reports Data from its Phase 1b Clinical Trial of NasoShield(TM)

Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, reported clinical data today on its NasoShield intranasal anthrax vaccine candidate. The Phase 1b trial evaluated the safety and...

ALT : 12.67 (+0.80%)
Analytica a�GBPa 1/2^adeg PeriCoach(R) ec'aJPY a-eGBPae�ae-aei^ae"'a�-e�aaoe'

- PeriCoach adegeEUR ea^e�a 1/4aeJPY anJPY a 1/4'aea 3/4'cs"c"ca 3/4OEe-caaaEUR e"e(TM)caEUR e-JPY ae^eEUR GBPe-a-a"JPY aSc"�e(C)�aaaea 3/4'aeoea'(TM)cs"c�aSa�adegc%a"GBPae�'c�cuia�-e-'a^eS-aEUR...

ALT : 12.67 (+0.80%)
A Analytica anuncia a expansao do PeriCoach(R), sua solucao de saude pelvica, para a China

- O PeriCoach sera distribuido por meio de uma extensa rede de centros de atendimento pos-parto, hospitais, redes de farmacias e plataformas on-line atendidas pelos parceiros da joint venture.

ALT : 12.67 (+0.80%)
Analytica kundigt Expansion der PeriCoach(R) Losung fur Beckengesundheit nach China an

- PeriCoach wird uber ein umfangreiches Netzwerk von postpartalen Versorgungszentren, Krankenhausern, Apothekenketten und Online-Plattformen von Joint Venture-Partnern vertrieben.

ALT : 12.67 (+0.80%)
Analytica anuncia la expansion de la solucion de salud para el suelo pelvico PeriCoach(R) en China

- PeriCoach se distribuira en una extensa red de centros de atencion posparto, hospitales, cadenas de farmacias y plataformas en linea a los que prestan servicios los socios de la empresa conjunta.

ALT : 12.67 (+0.80%)
Analytica Mengumumkan Perluasan Penyelesaian Kesihatan Pelvis PeriCoach(R) ke dalam China

- PeriCoach akan diedarkan melalui rangkaian pusat jagaan pascapartum, hospital, rangkaian farmasi dan platform dalam talian yang diservis oleh rakan kerjasama usaha sama yang meluas.

ALT : 12.67 (+0.80%)
aecaSaaaeGBPae"aEUR PeriCoach(R)ec'naOE"c(TM)eae 1/2aaJPY a 1/4ae-aa�a�aa' 1/2a�-e-'ae'c(TM)ei

- c"GBPa 3/4OEae�aecae- 1/2eaEUR c-...e(TM)caEUR e-a�EUR aaea 1/4a�a�a"a'aEUR aeaaena�a^a(TM)a�aaGBPa 1/4a'a 1/4a^aSa 1/4aOEaeua 1/4a"aeae'aea 3/4'a(TM)ae'aea�a(C)aena�a-a(C)aa^a-ae(C)a...

ALT : 12.67 (+0.80%)
Analytica, PeriCoach(R) e�edeg~ e�'edeg- i"eGBPi...~ in'eu e�ue% i(TM)-eOEEUR

- PeriCoach, i-(C)i' iOEOEiSe"^iee"ni' e�edegieeioe e�'ioei-~e� i^eS" e''e�"ioe"i-oe iedegi'"iidegei', e�'i', i- 1/2eu i�'i, i~e 1/4i i"OEe"i 1/4 e"niSi'OEieJPY 1/4 iui-' ioeiue i~^i-

ALT : 12.67 (+0.80%)
Analytica Announces Expansion of PeriCoach(R) Pelvic Health Solution into China

- PeriCoach will be distributed through extensive network of postpartum care centres, hospitals, pharmacy chains, and online platforms serviced by the joint venture partners.

ALT : 12.67 (+0.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Altimmune, Inc. is a clinical-stage immunotherapeutics company. It focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of disease. The company's proprietary platform technologies consist of RespirVec and Densigen. Altimmune Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 13.55
2nd Resistance Point 13.28
1st Resistance Point 12.98
Last Price 12.67
1st Support Level 12.41
2nd Support Level 12.14
3rd Support Level 11.84

See More

52-Week High 35.10
Fibonacci 61.8% 22.79
Fibonacci 50% 18.99
Fibonacci 38.2% 15.19
Last Price 12.67
52-Week Low 2.88

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar